Genomic Valley

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE574D01010
  • NSEID:
  • BSEID: 539206
INR
28.00
0.00 (0.00%)
BSENSE

Mar 27

BSE+NSE Vol: 2.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

No Fixed Assets in the last few periods;

stock-summary

Investments

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is -9.97% vs 12.79% in Mar 2024

Compare Balance Sheet Results of Genomic Valley
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.05
4.48
-1.43
-31.92%
Share Warrants & Outstandings
Total Reserve
0.84
-1.34
2.18
162.69%
Shareholder's Funds
3.90
3.14
0.76
24.20%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.00
0.00
0.00%
Current Liabilities
Trade Payables
0.01
1.17
-1.16
-99.15%
Other Current Liabilities
0.36
0.25
0.11
44.00%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.09
0.00
0.09
0.00%
Total Current Liabilities
0.46
1.41
-0.95
-67.38%
Total Liabilities
4.36
4.56
-0.20
-4.39%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.01
4.63
-4.62
-99.78%
Less: Accumulated Depreciation
0.00
3.43
-3.43
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.01
1.20
-1.19
-99.17%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
1.73
0.00
1.73
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
1.73
1.20
0.53
44.17%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.28
1.03
-0.75
-72.82%
Sundry Debtors
2.21
1.51
0.70
46.36%
Cash and Bank
0.05
0.64
-0.59
-92.19%
Other Current Assets
0.00
0.17
-0.17
-100.00%
Short Term Loans and Advances
0.08
0.00
0.08
0.00%
Total Current Assets
2.62
3.35
-0.73
-21.79%
Net Current Assets (Including Current Investments)
2.16
1.94
0.22
11.34%
Total Current Assets Excluding Current Investments
2.62
3.35
-0.73
-21.79%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
4.36
4.56
-0.20
-4.39%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
12.76
7.01
5.75
82.03%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 0.01 Cr
in Mar 2025

Figures in Cr
stock-summary

No Fixed Assets in the last few periods;

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

Annual - Current Assets
Current Assets 2.62 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -9.97% vs 12.79% in Mar 2024